Please provide your email address to receive an email when new articles are posted on . Patients with COPD and a history of asthma had a higher prevalence of elevated fractional exhaled nitric oxide ...
Researchers analyzed 22 studies to discover whether biomarkers help explain particulate matter (PM) exposure effects in patients with chronic obstructive pulmonary disease (COPD). Various biomarkers ...
NEW YORK, Nov. 7, 2019 /PRNewswire/ -- PulmOne USA Inc. has entered into a partnership agreement with Circassia Pharmaceuticals to offer the NIOX VERO ® fractional exhaled nitric oxide (FeNO) airway ...
The Fractional Exhaled Nitric Oxide (FeNO) test has long been part of clinical guidelines and was a key element in the previous asthma care recommendations from the National Institute for Health and ...
Approximately 339 million people around the world are afflicted with asthma, with asthma-related mortality affecting the lives of three families each day. Staggeringly, around two-thirds of these ...
A systematic review showed that a high fractional exhaled nitric oxide (FeNO) value before starting inhaled corticosteroid (ICS) therapy may be associated with higher response rates in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results